top of page

J Pharm Sci
Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles.
https://www.sciencedirect.com/science/article/pii/S0022354921005529?dgcid=coauthor
January 31th, 2022
J Pharm Sci
Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 1: Model for the Free-Drug Mixture
https://www.sciencedirect.com/science/article/abs/pii/S0022354921005475?dgcid=coauthor
December 9th, 2021
J Pharm Sci
Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates
https://www.sciencedirect.com/science/article/pii/S0022354920307486
January 15th, 2021

Frontiers in Pharmacology
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
https://www.frontiersin.org/articles/10.3389/fphar.2020.603242/full
January 15th, 2021
bottom of page